MeSH term
Frequency | Condition_Probility | Animals | 24 | 0.0 |
Humans | 44 | 0.0 |
Cell Line | 16 | 0.0 |
*Chromosome Aberrations | 2 | 0.0 |
DNA Repair/genetics | 3 | 1.0 |
DNA-Binding Proteins/genetics | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 32 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
*DNA Repair | 8 | 1.0 |
Gene Deletion | 2 | 0.0 |
Mutation | 6 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 23 | 0.0 |
Aged | 3 | 0.0 |
Cell Survival | 2 | 0.0 |
DNA Repair/*genetics | 10 | 3.0 |
DNA-Binding Proteins/*genetics | 8 | 0.0 |
Female | 7 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Genotype | 4 | 0.0 |
Middle Aged | 5 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
*Genetic Predisposition to Disease | 4 | 0.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
CHO Cells | 2 | 0.0 |
Chromosome Aberrations | 3 | 0.0 |
Cross-Linking Reagents/pharmacology | 3 | 2.0 |
*DNA Damage | 5 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Genetic Complementation Test | 8 | 1.0 |
*Genome | 3 | 2.0 |
Hamsters | 12 | 0.0 |
Mitomycin/pharmacology | 4 | 4.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Transfection | 7 | 0.0 |
Adult | 4 | 0.0 |
Case-Control Studies | 5 | 0.0 |
DNA Repair | 4 | 0.0 |
Male | 4 | 0.0 |
*Polymorphism, Genetic | 4 | 0.0 |
Comparative Study | 6 | 0.0 |
Time Factors | 3 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism/physiology | 2 | 12.0 |
Gamma Rays | 2 | 0.0 |
Hela Cells | 7 | 0.0 |
Macromolecular Substances | 3 | 0.0 |
Models, Biological | 3 | 0.0 |
Precipitin Tests | 8 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 15 | 0.0 |
DNA Damage | 7 | 0.0 |
X-Rays | 2 | 1.0 |
Cisplatin/*pharmacology | 2 | 1.0 |
DNA/metabolism | 3 | 0.0 |
DNA, Single-Stranded/*metabolism | 2 | 7.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Microscopy, Electron | 3 | 0.0 |
Protein Binding | 9 | 0.0 |
Baculoviridae/genetics | 2 | 1.0 |
DNA, Single-Stranded/metabolism | 3 | 4.0 |
Recombinant Proteins/metabolism | 4 | 0.0 |
Recombination, Genetic | 9 | 0.0 |
Blotting, Western | 3 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Insects | 2 | 1.0 |
Radiation Tolerance/genetics | 2 | 4.0 |
Mice | 4 | 0.0 |
Rabbits | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Phenotype | 2 | 0.0 |
*Recombination, Genetic | 6 | 1.0 |
Adenosine Triphosphate/metabolism | 2 | 0.0 |
Saccharomyces cerevisiae/genetics | 3 | 0.0 |
Two-Hybrid System Techniques | 3 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 3 | 1.0 |
Hybrid Cells | 4 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
*Endonucleases | 2 | 2.0 |
Nurses | 2 | 25.0 |
Risk Factors | 3 | 0.0 |
Smoking/adverse effects | 2 | 0.0 |
Base Sequence | 4 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Genetic Markers | 2 | 0.0 |
Prospective Studies | 2 | 0.0 |
*Chromosomes, Human, Pair 7 | 2 | 0.0 |
Binding Sites | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Thymidine/metabolism | 2 | 0.0 |
